ReviewPharmacoEconomics2012
A critical review of model-based economic studies of depression: modelling techniques, model structure and data sources.
Review in PharmacoEconomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Decision-Analytic Modelling Approaches in Economic Evaluations of Post-traumatic Stress Disorder Treatments.PharmacoEconomics · 2026Pooled it
- Research aimed at improving both mood and weight (RAINBOW) in primary care: A type 1 hybrid design randomized controlled trial.Contemporary clinical trials · 2015Trial
- Should the Spanish National Health System Invest in Psychotherapy for Depression? A Microsimulation Cost-Utility Study to Estimate the Economically Justifiable Price of Cognitive Behavioral Therapy Versus Anti-depressant Medication.Applied health economics and health policy · 2026Article
- Incorporating Complexity and System Dynamics into Economic Modelling for Mental Health Policy and Planning.PharmacoEconomics · 2024Article
- Cost-effectiveness analysis of mHealth applications for depression in Germany using a Markov cohort simulation.NPJ digital medicine · 2024Article
- A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process.PharmacoEconomics · 2022Review
- Value of monitoring negative emotional bias in primary care in England for personalised antidepressant treatment: a modelling study.Evidence-based mental health · 2019Article
- Model Structuring for Economic Evaluations of New Health Technologies.PharmacoEconomics · 2018Review
- Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review.PharmacoEconomics - open · 2017Review
- Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community.BMC health services research · 2013Article
- A proposed model for economic evaluations of major depressive disorder.The European journal of health economics : HEPAC : health economics in prevention and care · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression is the most common mental health disorder and is recognized as a chronic disease characterized by multiple acute episodes/relapses. Although modelling techniques play an increasingly important role in the economic evaluation of depression interventions, comparatively little attention has been paid to issues around modelling studies with a focus on potential biases. This, however, is important as different modelling approaches, variations in model structure and input parameters may produce different results, and hence different policy decisions. This paper presents a critical review of literature on recently published model-based cost-utility studies of depression. Taking depression as an illustrative example, through this review, we discuss a number of specific issues in relation to the use of decision-analytic models including the type of modelling techniques, structure of models and data sources. The potential benefits and limitations of each modelling technique are discussed and factors influencing the choice of modelling techniques are addressed. This review found that model-based studies of depression used various simulation techniques. We note that a discrete-event simulation may be the preferred technique for the economic evaluation of depression due to the greater flexibility with respect to handling time compared with other individual-based modelling techniques. Considering prognosis and management of depression, the structure of the reviewed models are discussed. We argue that a few reviewed models did not include some important structural aspects such as the possibility of relapse or the increased risk of suicide in patients with depression. Finally, the appropriateness of data sources used to estimate input parameters with a focus on transition probabilities is addressed. We argue that the above issues can potentially bias results and reduce the comparability of economic evaluations.
Indexed as
Identifiers
22462694What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.